First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy
Clinical trial NCT02644278 · COMPLETED
Trial details
- NCT number
- NCT02644278
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2017-10-19
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.